Clinical Trial Update: A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of Fasudil in individuals with amyotrophic lateral sclerosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• fasudil (fasudil)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN